DUBLIN--(BUSINESS WIRE)--The "Global Next Generation Sequencing (NGS) Market - Analysis and Forecast (2017-2024) (Focus on Product Type, Technology, Application, Country Analysis, Market Share Analysis, Funding Scenario, Trend Analysis, and Competitive Landscape)" report has been added to Research and Markets' offering.
The Global Next Generation Market was Estimated at $4.14 Billion in 2016 and is Estimated to Grow Over $11.92 Billion by 2024.
The Next Generation Sequencing (NGS) Industry is a multibillion market which consists of multitudinous companies involved in the manufacturing of instruments, kits & consumables, and development of software to bolster the NGS workflow.
Advancements in sequencing chemistry, molecular biology, and technical engineering over the years have profoundly increased the sequencing efficiency while decreasing the cost. Impressive progress in these fields have paved the way for development of massively parallel, high-throughput sequencing technology, known as Next Generation Sequencing (NGS).
The global next generation sequencing market is segmented by the geographical region into North America, Europe, Asia Pacific and Rest of the World (RoW). North America is a leading contributor to the global next generation sequencing market and contributed 50% of the global market values in 2016. However, Asia Pacific is expected to grow at 17.53% CAGR in the forecast period from 2017 to 2024. Moreover, the Asia Pacific market contributed approximately 13% of total global market value in 2016.
Key Topics Covered:
1 Report Scope & Methodology
2 Market Overview
3 Market Dynamics
4 Competitive Landscape
5 Funding Scenario
6 Industry Insights
7 Global Next Generation Sequencing Market by Product
8 Global Next Generation Sequencing Market by Technology
9 Global Next Generation Sequencing Market by Application
10 Global Next Generation Sequencing Market by Geography
11 Company Profiles
- 10x Genomics
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- GATC Biotech AG.
- GenapSys, Inc.
- Illumina, Inc.
- New England Biolabs, Inc.
- NuGEN Technologies Inc.
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California, Inc.
- Partek, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/87drcx/global_next